270 related articles for article (PubMed ID: 22048734)
1. CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice.
Nishimura Y; Ii M; Qin G; Hamada H; Asai J; Takenaka H; Sekiguchi H; Renault MA; Jujo K; Katoh N; Kishimoto S; Ito A; Kamide C; Kenny J; Millay M; Misener S; Thorne T; Losordo DW
J Invest Dermatol; 2012 Mar; 132(3 Pt 1):711-20. PubMed ID: 22048734
[TBL] [Abstract][Full Text] [Related]
2. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N
Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy accelerates diabetic wound closure.
Allen RJ; Soares MA; Haberman ID; Szpalski C; Schachar J; Lin CD; Nguyen PD; Saadeh PB; Warren SM
PLoS One; 2014; 9(3):e92667. PubMed ID: 24651576
[TBL] [Abstract][Full Text] [Related]
4. Mobilization of endothelial progenitor cells promotes angiogenesis after full thickness excision by AMD3100 combined with G-CSF in diabetic mice by SDF-1/CXCR4 axis.
Lin X; Wang H; Li X
Diab Vasc Dis Res; 2021; 18(2):14791641211002473. PubMed ID: 33779350
[TBL] [Abstract][Full Text] [Related]
5. Synergistic vasculogenic effects of AMD3100 and stromal-cell-derived factor-1α in vasa nervorum of the sciatic nerve of mice with diabetic peripheral neuropathy.
Kim BJ; Lee JK; Schuchman EH; Jin HK; Bae JS
Cell Tissue Res; 2013 Nov; 354(2):395-407. PubMed ID: 23942895
[TBL] [Abstract][Full Text] [Related]
6. Osteoprotegerin (OPG) Promotes Recruitment of Endothelial Progenitor Cells (EPCs) via CXCR4 Signaling Pathway to Improve Bone Defect Repair.
Zhang R; Liu J; Yu S; Sun D; Wang X; Fu J; Shen J; Xie Z
Med Sci Monit; 2019 Jul; 25():5572-5579. PubMed ID: 31350844
[TBL] [Abstract][Full Text] [Related]
7. The effect of estrogen on diabetic wound healing is mediated through increasing the function of various bone marrow-derived progenitor cells.
Zhuge Y; Regueiro MM; Tian R; Li Y; Xia X; Vazquez-Padron R; Elliot S; Thaller SR; Liu ZJ; Velazquez OC
J Vasc Surg; 2018 Dec; 68(6S):127S-135S. PubMed ID: 30064832
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis.
Song JS; Kang CM; Kang HH; Yoon HK; Kim YK; Kim KH; Moon HS; Park SH
Exp Mol Med; 2010 Jun; 42(6):465-72. PubMed ID: 20498529
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived CXCR4+ cells mobilized by macrophage colony-stimulating factor participate in the reduction of infarct area and improvement of cardiac remodeling after myocardial infarction in mice.
Morimoto H; Takahashi M; Shiba Y; Izawa A; Ise H; Hongo M; Hatake K; Motoyoshi K; Ikeda U
Am J Pathol; 2007 Sep; 171(3):755-66. PubMed ID: 17640962
[TBL] [Abstract][Full Text] [Related]
10. The effect of CXCL12 on endothelial progenitor cells: potential target for angiogenesis in intracerebral hemorrhage.
Li B; Bai W; Sun P; Zhou B; Hu B; Ying J
J Interferon Cytokine Res; 2015 Jan; 35(1):23-31. PubMed ID: 24955809
[TBL] [Abstract][Full Text] [Related]
11. AMD3100 mobilizes endothelial progenitor cells in mice, but inhibits its biological functions by blocking an autocrine/paracrine regulatory loop of stromal cell derived factor-1 in vitro.
Yin Y; Huang L; Zhao X; Fang Y; Yu S; Zhao J; Cui B
J Cardiovasc Pharmacol; 2007 Jul; 50(1):61-7. PubMed ID: 17666917
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction.
Jujo K; Hamada H; Iwakura A; Thorne T; Sekiguchi H; Clarke T; Ito A; Misener S; Tanaka T; Klyachko E; Kobayashi K; Tongers J; Roncalli J; Tsurumi Y; Hagiwara N; Losordo DW
Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11008-13. PubMed ID: 20534467
[TBL] [Abstract][Full Text] [Related]
13. Low-Dose Radiation Promotes the Proliferation and Migration of AGE-Treated Endothelial Progenitor Cells Derived from Bone Marrow via Activating SDF-1/CXCR4/ERK Signaling Pathway.
Wang P; Zhang H; Li Z; Liu X; Jin Y; Lei M; Jiao Z; Bi Y; Guo W
Radiat Res; 2019 Jun; 191(6):518-526. PubMed ID: 30925138
[TBL] [Abstract][Full Text] [Related]
14. CXC-chemokine receptor 4 antagonist AMD3100 promotes cardiac functional recovery after ischemia/reperfusion injury via endothelial nitric oxide synthase-dependent mechanism.
Jujo K; Ii M; Sekiguchi H; Klyachko E; Misener S; Tanaka T; Tongers J; Roncalli J; Renault MA; Thorne T; Ito A; Clarke T; Kamide C; Tsurumi Y; Hagiwara N; Qin G; Asahi M; Losordo DW
Circulation; 2013 Jan; 127(1):63-73. PubMed ID: 23204107
[TBL] [Abstract][Full Text] [Related]
15. Chronic AMD3100 antagonism of SDF-1alpha-CXCR4 exacerbates cardiac dysfunction and remodeling after myocardial infarction.
Dai S; Yuan F; Mu J; Li C; Chen N; Guo S; Kingery J; Prabhu SD; Bolli R; Rokosh G
J Mol Cell Cardiol; 2010 Oct; 49(4):587-97. PubMed ID: 20655922
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell-derived factor-1 receptor CXCR4-overexpressing bone marrow mesenchymal stem cells accelerate wound healing by migrating into skin injury areas.
Yang D; Sun S; Wang Z; Zhu P; Yang Z; Zhang B
Cell Reprogram; 2013 Jun; 15(3):206-15. PubMed ID: 23713431
[TBL] [Abstract][Full Text] [Related]
17. Topical simvastatin accelerates wound healing in diabetes by enhancing angiogenesis and lymphangiogenesis.
Asai J; Takenaka H; Hirakawa S; Sakabe J; Hagura A; Kishimoto S; Maruyama K; Kajiya K; Kinoshita S; Tokura Y; Katoh N
Am J Pathol; 2012 Dec; 181(6):2217-24. PubMed ID: 23138019
[TBL] [Abstract][Full Text] [Related]
18. Naringin enhances endothelial progenitor cell (EPC) proliferation and tube formation capacity through the CXCL12/CXCR4/PI3K/Akt signaling pathway.
Zhao Z; Ma X; Ma J; Sun X; Li F; Lv J
Chem Biol Interact; 2018 Apr; 286():45-51. PubMed ID: 29510123
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-C promotes vasculogenesis, angiogenesis, and collagen constriction in three-dimensional collagen gels.
Bauer SM; Bauer RJ; Liu ZJ; Chen H; Goldstein L; Velazquez OC
J Vasc Surg; 2005 Apr; 41(4):699-707. PubMed ID: 15874936
[TBL] [Abstract][Full Text] [Related]
20. Chemokine (C-X-C motif) receptor 4 blockade by AMD3100 inhibits experimental abdominal aortic aneurysm expansion through anti-inflammatory effects.
Michineau S; Franck G; Wagner-Ballon O; Dai J; Allaire E; Gervais M
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1747-55. PubMed ID: 24876351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
